Latest News
Our latest research, company updates and industry insight
Introducing Xiang Li – our new intern
We’re delighted to welcome Xiang Li to the ClearSky Medical Diagnostics team – she joined us on a 3-month internship in December. Xiang will be based at the ClearSky MD’s headquarters at the University of York. My name is Xiang Li and I recently finished my MSc in...
Bangalore trip for computational intelligence tutorial
Professor Stephen Smith travelled to Bangalore in November to co-lead a tutorial at the 2018 IEEE Symposium Series on Computational Intelligence (IEEE SSCI 2018). IEEE SSCI 2018 is an annual international conference organised by the IEEE Computational Intelligence...
ClearSky celebrates innovative medical technology
The ClearSky Medical Diagnostics team attended an event in Leeds in November celebrating collaboration and innovation in developing new medical technologies across the region.
ClearSky heads to Hong Kong for MDS 2018
ClearSky Medical Diagnostics will be heading to Hong Kong in October for the 22nd International Congress of Parkinson’s Disease and Movement Disorders (MDS).
Large study in China backs PD-Monitor for Parkinson’s diagnosis
ClearSky’s PD-Monitor can be used to confirm the diagnosis of Parkinson’s in very early stages based on the presence of bradykinesia in the dominant affected side, according to a groundbreaking study in China.
ClearSky celebrates Humies success at GECCO 2018
ClearSky Medical Diagnostics is proud to be part of an award-winning team that scooped top prize in the Human-Competitive Awards (Humies) 2018 in Japan.
ClearSky team heads to GECCO 2018
Members of the ClearSky team are finalists in the Human-Competitive Awards at the 2018 Genetic & Evolutionary Computation Conference (GECCO) in Japan.
Parkinson’s and statins: PD-Monitor in clinical study
ClearSky’s PD-Monitor has been used in a nationwide study to investigate whether statins are effective in slowing the progress of Parkinson’s.
Stephen’s Secondment Boosts Technology Development
ClearSky’s co-founder and director Professor Stephen Smith was recently awarded a secondment to evaluate the technology for measuring the symptoms of Parkinson’s. Professor Stephen Smith, Deputy Head of the Department of Electronic Engineering at the University of...
ClearSky expands team with key appointments
ClearSky Medical Diagnostics is delighted to announce the appointment of two new members of staff – Dr Marta Vallejo and Dr Amir Dehsarvi.
How LID-Monitor can help save the NHS money
Implementing ClearSky’s LID-Monitor in UK hospitals ‘has the potential to reduce costs to the NHS and increase the quality of life of people with Parkinson’s’…
What is levodopa-induced dyskinesia?
Levodopa is the most effective and commonly used drug for treating Parkinson’s. It is a chemical building-block that your body converts into dopamine. People with Parkinson’s lack enough dopamine because some of the brain cells that make it have died. The loss of...